Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine

M Papp, V Klimek, P Willner - Psychopharmacology, 1994 - Springer
M Papp, V Klimek, P Willner
Psychopharmacology, 1994Springer
Chronic sequential exposure to a variety of mild stressors has previously been found to
cause an antidepressant-reversible decrease in the consumption of palatable sweet
solutions, associated with abnormalities of dopaminergic neurotransmission in the nucleus
accumbens. In the present study, 5 weeks of treatment with imipramine (10 mg/kg bid)
reversed the decreased sucrose intake of rats exposed to chronic mild stress. Stress also
caused a decrease in D 2-receptor binding in the limbic forebrain (but not the striatum) …
Abstract
Chronic sequential exposure to a variety of mild stressors has previously been found to cause an antidepressant-reversible decrease in the consumption of palatable sweet solutions, associated with abnormalities of dopaminergic neurotransmission in the nucleus accumbens. In the present study, 5 weeks of treatment with imipramine (10 mg/kg b.i.d.) reversed the decreased sucrose intake of rats exposed to chronic mild stress. Stress also caused a decrease in D2-receptor binding in the limbic forebrain (but not the striatum), which was completely reversed by imipramine. In nonstressed animals, imipramine decreased D1-receptor binding in both regions. However, in stressed animals, imipramine did not significantly alter D1-receptor binding in either area. Stress alone slightly increased D1-receptor binding, in striatum only. Scatchard analysis showed that all changes in receptor binding resulted from changes in receptor number (Bmax) rather than receptor affinity (KD). The results support the hypothesis that changes in D2-receptor function in the nucleus accumbens are responsible for chronic mild stress-induced anhedonia and its reversal by antidepressant drugs. They do not support the hypothesis that the sensitization of D2-receptors seen following chronic antidepressant treatment is caused by a down-regulation of D1-receptors.
Springer